Engineered Tissue for Cardiac Regeneration: Current Status and Future Perspectives

Heart failure (HF) is the leading cause of death worldwide. The most effective HF treatment is heart transplantation, the use of which is restricted by the limited supply of donor hearts. The human pluripotent stem cell (hPSC), including human embryonic stem cell (hESC) and the induced pluripotent s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junjun, Liu, Li, Zhang, Jingbo, Qu, Xiang, Kawamura, Takuji, Miyagawa, Shigeru, Sawa, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688015/
https://www.ncbi.nlm.nih.gov/pubmed/36354516
http://dx.doi.org/10.3390/bioengineering9110605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688015/
https://www.ncbi.nlm.nih.gov/pubmed/36354516
http://dx.doi.org/10.3390/bioengineering9110605

Ejemplares similares